Steroid profiles of transgenic tobacco expressing an Actinomyces 3-hydroxysteroid oxidase gene

Abstract

Previously, we have shown that the expression of a 3-hydroxysteroid-oxidase gene in transgenic tobacco initiated a series of biochemical events leading to the conversion of sterol to stanol. As a result, the plants maintained a diminished sterol pool and a modified relative sterol ratio but demonstrated no observable morphological abnormalities. The maintenance of normal higher plant physiology in the absence of particular sterols or in the presence of modified sterol ratios is controversial. In this report, we present additional biochemical and physiological characteristics of transgenic tobacco expressing an Actinomyces 3-hydroxysteroid-oxidase gene. The total steroid accumulated in the transgenic plants is 6-fold higher than in control plants and consists of sterol, 3-ketosteroid and stanol. The relative abundance of sterols within whole plant and individual organs is grossly altered as ethylated side chain sterols account for 99% of the total sterol pool in the transgenic tobacco. Stigmasterol is readily apparent in all tissues and cholesterol is found at measurable levels in specific organs, while campesterol and sitosterol are detected at trace levels in the transgenic plants. Stanols and 3-ketosteroids accumulate in all tissues and represent 77% of the measurable steroid pool in the transgenic plants. The sum of sterol, the respective 3-ketosteroid plus stanol provide a relative abundance of steroid, which is similar to the abundance of sterol accumulated in control tissue. In vitro photosynthetic electron transport measurements demonstrate altered activity of chloroplasts under a variety of reaction conditions, indicating a link between the modified steroid pool and a modulation of chloroplast membrane function.